Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Robledo

Showing results (81-90 of 217) with videos related to

Pageof 22
Sort By:
Cancer Genetics and Cytogenetics|June 1, 1997
Cytogenetic and molecular studies of siblings with ataxia telangiectasia followed for 7 yearsM Renedo, M Robledo, E Arranz, et al.
Frontiers in Cellular and Infection Microbiology|October 19, 2018
Transforming Growth Factor Beta (TGFβ1) and Epidermal Growth Factor (EGF) as Biomarkers of <i>Leishmania (V) braziliensis</i> Infection and Early Therapeutic Response in Cutaneous Leishmaniasis: Studies in HamstersAndrés Montoya, Lina Yepes, Alexander Bedoya, et al.
Molecules (Basel, Switzerland)|July 16, 2020
Alkyl and Aryl Derivatives Based on <i>p</i>-Coumaric Acid Modification and Inhibitory Action against <i>Leishmania braziliensis</i> and <i>Plasmodium falciparum</i>Susiany P Lopes, Lina M Yepes, Yunierkis Pérez-Castillo, et al.
Biotechnology Reports (Amsterdam, Netherlands)|July 4, 2020
Corrigendum to "Enzymatic, antimicrobial, and leishmanicidal bioactivity of gram-negative bacteria strains from the midgut of <i>Lutzomyia evansi</i>, an insect vector of leishmaniasis in Colombia" [Biotechnol. Rep. 24 (2019) 1-9]Rafael J Vivero, Gustavo Bedoya Mesa, Sara M Robledo, et al.
Transfusion|March 12, 2011
Transfusion-transmitted visceral leishmaniasis caused by Leishmania (Leishmania) mexicana in an immunocompromised patient: a case reportLaureano Mestra, Liliana Lopez, Sara M Robledo, et al.
Parasitology|May 14, 2016
A non-commercial approach for the generation of transgenic Leishmania tarentolae and its application in antileishmanial drug discoveryTatiana Pineda, Yesenia Valencia, María F Flórez, et al.
Mycopathologia|June 18, 1976
Pathogenesis of paracoccidioidomycosis: a model based on the study of 46 patientsR Giraldo, A Restrepo, F Gutiérrez, et al.
Biotechnology Reports (Amsterdam, Netherlands)|October 24, 2019
Enzymatic, antimicrobial, and leishmanicidal bioactivity of gram-negative bacteria strains from the midgut of <i>Lutzomyia evansi</i>, an insect vector of leishmaniasis in ColombiaRafael J Vivero, Gustavo Bedoya Mesa, Sara M Robledo, et al.
Molecules (Basel, Switzerland)|November 21, 2014
Preparation of rotenone derivatives and in vitro analysis of their antimalarial, antileishmanial and selective cytotoxic activitiesYulieth Upegui, Juan F Gil, Wiston Quiñones, et al.
Anales Espanoles De Pediatria|April 1, 1992
[Cytogenetic study of a family with 15p+ chromosomal plymorphism]A I Manzanal Martínez, M Robledo Batanero, C Ramos Corrales, et al.
Pageof 22

Showing results (81-90 of 217) with videos related to

Sort By:
Pageof 22
Cancer Genetics and Cytogenetics|June 1, 1997
Cytogenetic and molecular studies of siblings with ataxia telangiectasia followed for 7 yearsM Renedo, M Robledo, E Arranz, et al.
Frontiers in Cellular and Infection Microbiology|October 19, 2018
Transforming Growth Factor Beta (TGFβ1) and Epidermal Growth Factor (EGF) as Biomarkers of <i>Leishmania (V) braziliensis</i> Infection and Early Therapeutic Response in Cutaneous Leishmaniasis: Studies in HamstersAndrés Montoya, Lina Yepes, Alexander Bedoya, et al.
Molecules (Basel, Switzerland)|July 16, 2020
Alkyl and Aryl Derivatives Based on <i>p</i>-Coumaric Acid Modification and Inhibitory Action against <i>Leishmania braziliensis</i> and <i>Plasmodium falciparum</i>Susiany P Lopes, Lina M Yepes, Yunierkis Pérez-Castillo, et al.
Biotechnology Reports (Amsterdam, Netherlands)|July 4, 2020
Corrigendum to "Enzymatic, antimicrobial, and leishmanicidal bioactivity of gram-negative bacteria strains from the midgut of <i>Lutzomyia evansi</i>, an insect vector of leishmaniasis in Colombia" [Biotechnol. Rep. 24 (2019) 1-9]Rafael J Vivero, Gustavo Bedoya Mesa, Sara M Robledo, et al.
Transfusion|March 12, 2011
Transfusion-transmitted visceral leishmaniasis caused by Leishmania (Leishmania) mexicana in an immunocompromised patient: a case reportLaureano Mestra, Liliana Lopez, Sara M Robledo, et al.
Parasitology|May 14, 2016
A non-commercial approach for the generation of transgenic Leishmania tarentolae and its application in antileishmanial drug discoveryTatiana Pineda, Yesenia Valencia, María F Flórez, et al.
Mycopathologia|June 18, 1976
Pathogenesis of paracoccidioidomycosis: a model based on the study of 46 patientsR Giraldo, A Restrepo, F Gutiérrez, et al.
Biotechnology Reports (Amsterdam, Netherlands)|October 24, 2019
Enzymatic, antimicrobial, and leishmanicidal bioactivity of gram-negative bacteria strains from the midgut of <i>Lutzomyia evansi</i>, an insect vector of leishmaniasis in ColombiaRafael J Vivero, Gustavo Bedoya Mesa, Sara M Robledo, et al.
Molecules (Basel, Switzerland)|November 21, 2014
Preparation of rotenone derivatives and in vitro analysis of their antimalarial, antileishmanial and selective cytotoxic activitiesYulieth Upegui, Juan F Gil, Wiston Quiñones, et al.
Anales Espanoles De Pediatria|April 1, 1992
[Cytogenetic study of a family with 15p+ chromosomal plymorphism]A I Manzanal Martínez, M Robledo Batanero, C Ramos Corrales, et al.
Pageof 22